Alcon AG vs Cigna Corp — how do they compare? Alcon AG trades at $72.42 (market cap $36.44B), while Cigna Corp trades at $273 (market cap $73.56B). The key difference: Cigna Corp is far larger — about 2× Alcon AG's market cap, and Cigna Corp pays the higher dividend (2.24%). Which is the better fit depends on your goals.
| ALC | CI | |
|---|---|---|
Market Cap | $36.44B | $73.56B |
Sector | Health | Health |
52-Week High | $90.12 | $311.00 |
52-Week Low | $62.02 | $244.41 |
Enterprise Value | $40.28B | $98.27B |
Dividend Yield | 0.48% | 2.24% |
Trailing returns across standard periods
Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with only about 40% of revenue from the U.S. market, and the firm has a strong presence in the European Union and Japan.
Read more on ALC →Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →